# Cornerstone Specialty Network: Cornerstone provides long\-term, sustainable value through an aggregated network of community\-based oncology practices\. > Cornerstone Specialty Network provides long\-term, sustainable value through an aggregated network of community\-based oncology practices\. Generated by Yoast SEO v27.9, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [About Us](https://www.cornerstoneoncology.com/about/) - [Events](https://www.cornerstoneoncology.com/events/) - [Oncology Insights](https://www.cornerstoneoncology.com/oncology-insights/) - [Educational Initiatives](https://www.cornerstoneoncology.com/our-focus/educational-initiatives/) - [Life Sciences](https://www.cornerstoneoncology.com/life-sciences/) ## Posts - [Cornerstone’s Network Connection: Issue No\. 27](https://www.cornerstoneoncology.com/may-newesletter/) - [Cornerstone Specialty Network and Knowtex Announce Strategic Partnership to Advance AI\-Driven Clinical Workflows and Operational Efficiency Nationwide](https://www.cornerstoneoncology.com/cornerstone-specialty-network-and-knowtex-announce-strategic-partnership-to-advance-ai-driven-clinical-workflows-and-operational-efficiency-nationwide/) - [Cornerstone’s Network Connection: Issue No\. 26](https://www.cornerstoneoncology.com/cornerstones-network-connection-issue-no-26/) - [Cornerstone’s Network Connection: Issue No\. 25](https://www.cornerstoneoncology.com/cornerstones-network-connection-issue-no-25/) - [Cornerstone’s Network Connection Newsletter: Issue No\. 23](https://www.cornerstoneoncology.com/cornerstones-network-connection-newsletter-issue-no-23/) ## Challenging Cases - [Challenging Cases in Small Cell Lung Cancer, Report Q4](https://www.cornerstoneoncology.com/case/challenging-cases-in-small-cell-lung-cancer-report-q4/) - [Challenging Cases in Triple Negative Breast Cancer, Report 2025](https://www.cornerstoneoncology.com/case/challenging-cases-in-triple-negative-breast-cancer-report-2025/) - [Challenging Cases in Skin Cancer: Metastatic Melanoma, Q3\-Q4 2025](https://www.cornerstoneoncology.com/case/challenging-cases-in-skin-cancer-metastatic-melanoma-q3-q4-2025/) - [Challenging Cases in Systemic Mastocytosis, Report 2025](https://www.cornerstoneoncology.com/case/challenging-cases-in-systemic-mastocytosis-report-2025/) - [Challenging Cases in Desmoid Tumors, Report 2025](https://www.cornerstoneoncology.com/case/challenging-cases-in-desmoid-tumors-report-2025/) ## Events - [National Cornerstone Corners, 6:30PM](https://www.cornerstoneoncology.com/event/national-cornerstone-corners-630pm/) - [National Cornerstone Corners, 8:00PM](https://www.cornerstoneoncology.com/event/national-cornerstone-corners-800pm/) - [COLAI](https://www.cornerstoneoncology.com/event/colai/): Community Oncology Fellowship Advancement Initiative \(COFAI\) Specifically customized for oncologists who are new to the community setting with the goal of accelerating quality patient care\. - [Applications for Community Oncology: Lung](https://www.cornerstoneoncology.com/event/applications-for-community-oncology-lung-3/) - [Applications for Community Oncology: Business of Oncology Symposium](https://www.cornerstoneoncology.com/event/applications-for-community-oncology-business-of-oncology-symposium-2/) ## Labs - [Blueprint\-sponsored Biomarker Testing Program](https://www.cornerstoneoncology.com/lab/blueprint-sponsored-biomarker-testing-program/) - [Labcorp](https://www.cornerstoneoncology.com/lab/labcorp/) - [Virant Diagnostics](https://www.cornerstoneoncology.com/lab/virant-diagnostics/) - [Mayo Clinic Laboratories](https://www.cornerstoneoncology.com/lab/mayo-clinic-laboratories/) - [ARUP Laboratories](https://www.cornerstoneoncology.com/lab/arup-laboratories/) ## Resources - [OncoPulse RR Mantle Cell Lymphoma](https://www.cornerstoneoncology.com/resource/1302/) - [2026 Q1 Challenging Cases Triple Negative Breast Cancer](https://www.cornerstoneoncology.com/resource/2026-q1-challenging-cases-triple-negative-breast-cancer/) - [2026 Q1 Challenging Cases SCLC](https://www.cornerstoneoncology.com/resource/2026-q1-challenging-cases-sclc/) - [2026 Q1 Challenging Cases Renal Cell Carcinoma](https://www.cornerstoneoncology.com/resource/2026-q1-challenging-cases-renal-cell-carcinoma/) - [Challenging Cases in Endometrial Cancer HER2\+ Report Q3\-Q4 2025](https://www.cornerstoneoncology.com/resource/challenging-cases-in-endometrial-cancer-her2-report-q3-q4-2025/) ## Applications - [National Summit](https://www.cornerstoneoncology.com/application/national-summit/) - [ESMO](https://www.cornerstoneoncology.com/application/esmo/) - [SABCS](https://www.cornerstoneoncology.com/application/sabcs/) - [ASH](https://www.cornerstoneoncology.com/application/ash/) - [ASCO](https://www.cornerstoneoncology.com/application/asco/) ## Brands - [Cabometyx](https://www.cornerstoneoncology.com/brand/final-cabometyx/) - [Past Cabometyx](https://www.cornerstoneoncology.com/brand/cabometyx/) - [ROLVEDON®](https://www.cornerstoneoncology.com/brand/rolvedon/) ## Optional - [Sitemap index](https://www.cornerstoneoncology.com/sitemap_index.xml)